Use the Back button in your browser to see the other results of your search or to select another record.
| Telefonisches Gesundheitscoaching und telemetrisch unterstutztes Training (TeGeCoach) bei peripherer arterieller verschlusskrankheit (Telephone health coaching and remote exercise monitoring (TeGeCoach) in peripheral arterial occlusive disease -- a randomized controlled trial) [German] |
| Rezvani F, Heider D, Konig H-H, Herbarth L, Steinisch P, Schuhmann F, Bobinger H, Krack G, Korth T, Thomsen L, Chase DP, Schreiber R, Alscher M-D, Finger B, Harter M, Dirmaier J |
| Deutsches Arzteblatt International 2024 May 17;121(10):323-330 |
| clinical trial |
| This trial has not yet been rated. |
|
BACKGROUND: Supervised exercise programs are commonly used to treat intermittent claudication (IC). Home-based exercise programs have been developed to lower barriers to participation. We studied the effects of one such program (TeGeCoach) on self-reported walking ability in patients with IC. METHODS: In a pragmatic, multicenter, randomized and controlled trial (registration number NCT03496948), 1982 patients with symptomatic IC, insured by one of three German statutory health-insurance carriers, received either telephone health coaching with remote exercise monitoring (TeGeCoach; n = 994) or routine care (n = 988). The primary outcome was the change in Walking Impairment Questionnaire (WIQ) scores 12 and 24 months after the start of the intervention (intention-to-treat analysis). The secondary outcomes were health-related quality of life, symptoms of depression or anxiety, health competence, patient activation, alcohol use, and nicotine dependence. RESULTS: There was a significant difference between arms in favor of TeGeCoach in the WIQ (p < 0.0001). Patients in the TeGeCoach arm had WIQ scores that were 6.30 points higher at 12 months (Bonferroni-corrected 95% CI (4.02; 8.59), Cohen's d = 0.26) and 4.55 points higher at 24 months ((2.20; 6.91), d = 0.19). They also fared better in some of the secondary outcomes at 12 months, including physical health-related quality of life and patient activation, with at least small effect sizes (d > 0.20). The average daily step count was no higher in the TeGeCoach group. CONCLUSION: The observed reductions of symptom burden indicate the benefit of home-based exercise programs in the treatment of intermittent claudication. Such programs expand the opportunities for the guideline-oriented treatment of IC. Future studies should address the effect of home-based exercise programs on clinical variables, eg, the 6-minute walk test.
|